A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Expert Opinions

General MM,Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Following NICE guidelines | An interview with Ceri Bygrave

Mar 29, 2018

Latest Drug Updates

Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Galinpepimut-S granted FDA orphan drug designation

May 11, 2018
Patients eligible for transplant,Patients non-eligible for transplant

Daratumumab approved by FDA for frontline use

May 8, 2018
Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Apr 13, 2018

Where we are next

The 4th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy)

May 3-5, 2018 | Paris, France

The Multiple Myeloma Hub will be attending the 2018 Controversies in Multiple Myeloma meeting in Paris from 3-5 May 2018. Some of the biggest names in Multiple Myeloma will gather together to discuss the latest advances in treatment and guidelines for disease management, in the form of talks, case studies, and active debate. Stay tuned to the MM Hub to follow for our first-hand coverage.

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology